Bactana’s microbiome discovery platform enables development of products and therapeutics through the use of recent advances in molecular and DNA sequencing methods used to study microbial ecology. This platform allows Bactana to concentrate its product development on the interaction of an animal’s microbiome with its immune system & metabolism (immunometabolism) at an accelerated pace. Bactana’s initial focus is on its patented FPS™ product line which is supported by multiple calf trials that have demonstrated scours reduction, increased milk production, reduced mortality, improved feed efficiency, and growth. FPS is expected to provide similar benefits for swine, poultry, and other animals. Bactana has developed a breakthrough product with FPS and will continue making new discoveries related to the animal microbiome.